Cognitive Disturbances in Parkinson's Disease

Disease-a-Month

Volumn 53, Issue 5, 2007, Pages 302-308

  Grujic, Zoran ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

COGNITIVE DEFECT; DEMENTIA; DIAGNOSTIC IMAGING; HUMAN; LEWY BODY; NEUROPSYCHOLOGY; PARKINSON DISEASE; PREVALENCE; REVIEW;

CHOLINESTERASE INHIBITORS; DEMENTIA; DISEASE PROGRESSION; HUMANS; LEWY BODY DISEASE; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; RISK FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 34447531921     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.disamonth.2007.02.007     Document Type: Review

References (16)

1. Cummings J.L. Intellectual impairment in Parkinson's disease: clinical, pathologic, and biochemical correlates. J Geriatr Psychiatry Neurol 1 (1988) 24-36
2. Aarsland D., Andersen K., Larsen J.P., et al. Risk of dementia in Parkinson's disease: a community based prospective study. Neurology 56 (2001) 730-736
3. Mayeux R., Denaro J., Hemenegildo N., et al. A population-based investigation of Parkinson's disease with and without dementia: relationship to age and gender. Arch Neurol 49 (1992) 492-497
4. Reid W.G., Hely M.A., Morris J.G., et al. A longitudinal study of Parkinson's disease: clinical and neuropsychological correlates of dementia. J Clin Neuroci 3 (1996) 327-333
5. Rashkin S.A., Borod J.C., and Tweedy J. Neuropsychological aspects of Parkinson's disease. Neuropsychol Rev 1 (1990) 185-219
6. Bissesser S., Tissingh G., and Wolters E.C. CBF SPECT in Parkinson's disease patients with mental dysfunction. J Neural Transm Suppl 50 (1997) 25-30
7. Firbank M.J., Colloby S.J., Burn D.J., et al. Regional Cerebral blood flow in Parkinson's disease with and without dementia. Neuroimage 20 (2003) 1309-1319
8. Boeve B.F., Silber M.H., and Ferman T.J. REM sleep behavior disorder in Parkinson's disease and dementia with Lewy bodies. J Geriatr Psychiatry Neurol 17 3 (2004) 146-157
9. Hurtig H.I., Trojanowski J.Q., Galvin J., et al. Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology 54 (2000) 1916-1921
10. Perry E.K., Kilford L., Lees A.J., et al. Increased Alzheimer Pathology in Parkinson's Disease related to antimuscarinic drugs. Ann Neurol 54 2 (2003) 144-146
11. Candy J.M., Perry R.H., Perry E.K., et al. Pathological changes in the nucleus of Maynert in Alzheimer's and Parkinson's disease. J Neurol Sci 59 (1983) 277-289
12. Mattila P.M., Roytta M., Lonnberg P., et al. Choline acetyltransferase activity and striatal dopamine receptors in Parkinson's disease in relation to cognitive impairment. Acta Neuropathol 102 (2001) 160-166
13. Aarsland D., Larsen J.P., Janvin C., et al. Donepezil treatment in Pakinson's disease with dementia; a double blind, placebo-controlled crossover study. J Neurol Neurosurg Psychiatry 72 (2002) 708-712
14. Emre M., Aarsland D., Albanese A., et al. Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med 351 24 (2004) 2547-2549
15. McKeith I., Del Ser T., Spano P.-F., et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomized, double blind, placebo controlled international study. Lancet 356 (2000) 2031-2036
16. Levy G., Tang M.X., Cote L.J., et al. Motor impairment in PD: relationship to incident dementia and age. Neurology 55 (2000) 539-544